title: TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis.
authors.forename: D
authors.initials: D
authors.lastname: Bowen
authors.forename: M J
authors.initials: MJ
authors.lastname: Groves
authors.forename: A K
authors.initials: AK
authors.lastname: Burnett
authors.forename: Y
authors.initials: Y
authors.lastname: Patel
authors.forename: C
authors.initials: C
authors.lastname: Allen
authors.forename: C
authors.initials: C
authors.lastname: Green
authors.forename: R E
authors.initials: RE
authors.lastname: Gale
authors.forename: R
authors.initials: R
authors.lastname: Hills
authors.forename: D C
authors.initials: DC
authors.lastname: Linch
mesh_terms: D006801:Humans; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000235:genetics*; D009154:Mutation; D015995:Prevalence; D011379:Prognosis; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
chemical_list: D016159:Tumor Suppressor Protein p53